|
1
|
Berthelot L, Papista C, Maciel TT,
Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin A,
Bex-Coudrat J, Gestin A, et al: Transglutaminase is essential for
IgA nephropathy development acting through IgA receptors. J Exp
Med. 209:793–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riispere Ž, Kuudeberg A, Seppet E, Sepp K,
Ilmoja M, Luman M, Kõlvald K, Auerbach A and Ots-Rosenberg M:
Significance of clinical and morphological prognostic risk factors
in IgA nephropathy: Follow-up study of comparison patient groups
with and without renoprotection. BMC Nephrol. 18:892017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fiorentino M, Bolignano D, Tesar V, Pisano
A, Van Biesen W, D'Arrigo G, Tripepi G and Gesualdo L: ERA-EDTA
Immunonephrology Working Group: Renal biopsy in 2015-from
epidemiology to evidence-based indications. Am J Nephrol. 43:1–19.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le WB and Liu ZH: Prognostic indicators
and treatment of IgA Nephropathy in China. Pathogen Treat IgA
Nephropat. 127–139. 2016. View Article : Google Scholar
|
|
5
|
Wyatt RJ and Julian BA: IgA Nephropathy. N
Engl J Med. 368:2402–2414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boyd JK, Cheung CK, Molyneux K, Feehally J
and Barratt J: An update on the pathogenesis and treatment of IgA
nephropathy. Kidney Int. 81:833–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gharavi AG, Kiryluk K, Choi M, Li Y, Hou
P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, et al:
Genome-wide association study identifies susceptibility loci for
IgA nephropathy. Nat Genet. 43:321–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki H, Kiryluk K, Novak J, Moldoveanu
Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG
and Julian BA: The pathophysiology of IgA nephropathy. J Am Soc
Nephrol. 22:1795–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mekori YA, Hershko AY, Frossi B, Mion F
and Pucillo CE: Integrating innate and adaptive immune cells: Mast
cells as crossroads between regulatory and effector B and T cells.
Eur J Pharmacol. 778:84–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han Y, Li H, Guan Y and Huang J: Immune
repertoire: A potential biomarker and therapeutic for
hepatocellular carcinoma. Cancer Lett. 379:206–212. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou X, Lu C, Chen S, Xie Q, Cui G, Chen J,
Chen Z, Wu Z, Ding Y, Ye P, et al: High throughput sequencing of T
cell antigen receptors reveals a conserved TCR repertoire. Medicine
(Baltimore). 95:e28392016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Madi A, Shifrut E, Reich-Zeliger S, Gal H,
Best K, Ndifon W, Chain B, Cohen IR and Friedman N: T-cell receptor
repertoires share a restricted set of public and abundant CDR3
sequences that are associated with self-related immunity. Genome
Res. 24:1603–1612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu H, Zhang GY, Clarkson AR and Knight JF:
Conserved T-cell receptor beta chain CDR3 sequences in IgA
nephropathy biopsies. Kidney Int. 55:109–119. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Connell AE, Volpi S, Dobbs K, Fiorini C,
Tsitsikov E, de Boer H, Barlan IB, Despotovic JM, Espinosa-Rosales
FJ, Hanson IC, et al: Next generation sequencing reveals skewing of
the T and B cell receptor repertoires in patients with
wiskott-Aldrich syndrome. Front Immunol. 5:3402014.PubMed/NCBI
|
|
15
|
Suzuki K, Honda K, Tanabe K, Toma H, Nihei
H and Yamaguchi Y: Incidence of latent mesangial IgA deposition in
renal allograft donors in Japan. Kidney Int. 63:2286–2294. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee HS, Lee MS, Lee SM, Lee SY, Lee ES,
Lee EY, Park SY, Han JS, Kim S and Lee JS: Histological grading of
IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's
glomerular grading system. Nephrol Dial Transplant. 20:342–348.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hou X, Chen J, Lu C, Wang L and Wu W: The
conserved T cell receptor repertoire observed in patients with
systemic lupus erythematosus. Int J Clin Exp Med. 10:2053–2065.
2017.
|
|
18
|
Liu S, Hou XL, Sui WG, Lu QJ, Hu YL and
Dai Y: Direct measurement of B-cell receptor repertoire's
composition and variation in systemic lupus erythematosus. Genes
Immun. 18:22–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guda K, Veigl ML, Varadan V, Nosrati A,
Ravi L, Lutterbaugh J, Beard L, Willson JK, Sedwick WD, Wang ZJ, et
al: Novel recurrently mutated genes in African American colon
cancers. Proc Natl Acad Sci USA. 112:pp. 1149–1154. 2015;
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meyer EH, Hsu AR, Liliental J, Löhr A,
Florek M, Zehnder JL, Strober S, Lavori P, Miklos DB, Johnson DS
and Negrin RS: A distinct evolution of the T-cell repertoire
categorizes treatment refractory gastrointestinal acute
graft-versus-host disease. Blood. 121:4955–4962. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar S, Stecher G and Tamura K: MEGA7:
Molecular evolutionary genetics analysis version 7.0 for bigger
datasets. Mol Biol Evol. 33:1870–1874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu H, Wang C, Liu X, Zhao Y and Zhang W:
Characterization of the T cell receptor repertoires during
pregnancy. Biomed Res. 28:1161–1166. 2017.
|
|
23
|
Borroto A, Reyes-Garau D, Jiménez MA,
Carrasco E, Moreno B, Martínez-Pasamar S, Cortés JR, Perona A, Abia
D, Blanco S, et al: First-in-class inhibitor of the T cell receptor
for the treatment of autoimmune diseases. Sci Transl Med.
8:370ra1842016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Renfrow MB and Novak J: What insights can
proteomics give us into IgA nephropathy (Berger's disease)? Expert
Rev Proteomics. 14:645–647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rasche FM, Keller F, Rasche WG, Schiekofer
S, Boldt A, Sack U and Fahnert J: Why, when and how should
immunosuppressive therapy considered in patients with
immunoglobulin A nephropathy. Clin Exp Immunol. 186:115–133. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim MJ, Schaub S, Molyneux K, Koller MT,
Stampf S and Barratt J: Effect of immunosuppressive drugs on the
changes of serum galactose-deficient IgA1 in patients with IgA
nephropathy. PLoS One. 11:e01668302016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Callan CG Jr, Mora T and Walczak AM:
Repertoire sequencing and the statistical ensemble approach to
adaptive immunity. Curr Opin Syst Biol. 1:44–47. 2017. View Article : Google Scholar
|
|
28
|
Hou XL, Wang L, Ding YL, Xie Q and Diao
HY: Current status and recent advances of next generation
sequencing techniques in immunological repertoire. Genes Immun.
17:153–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berry R and Call ME: Modular activating
receptors in innate and adaptive immunity. Biochemistry.
56:1383–1402. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krell PF, Reuther S, Fischer U, Keller T,
Weber S, Gombert M, Schuster FR, Asang C, Stepensky P, Strahm B, et
al: Next-generation-sequencing-spectratyping reveals public T-cell
receptor repertoires in pediatric very severe aplastic anemia and
identifies a β chain CDR3 sequence associated with
hepatitis-induced pathogenesis. Haematologica. 98:1388–1396. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aouinti S, Malouche D, Giudicelli V,
Kossida S and Lefranc MP: IMGT/HighV-QUEST statistical significance
of IMGT clonotype (AA) diversity per gene for standardized
comparisons of next generation sequencing immunoprofiles of
immunoglobulins and T cell receptors. PLoS One. 10:e01423532015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saada R, Weinberger M, Shahaf G and Mehr
R: Models for antigen receptor gene rearrangement: CDR3 length.
Immunol Cell Biol. 85:323–332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kitaura K, Shini T, Matsutani T and Suzuki
R: A new high-throughput sequencing method for determining
diversity and similarity of T cell receptor (TCR) α and β
repertoires and identifying potential new invariant TCR α chains.
BMC Immunol. 17:382016. View Article : Google Scholar : PubMed/NCBI
|
